IMMUNE DESIGN CORP. 4 SEC Filings

Filed On	Filing
04 Apr 2019	Form 4: Berger Franklin M, Director Returned 75,000 shares to the issuer ($439K) · Disposed of 35,000 Stock Option (Rt to Buy) (Disposition to Issuer)
04 Apr 2019	Form 4: Baltimore David, Director Returned 78,287 shares to the issuer ($458K) · Disposed of 42,339 Stock Option (Rt to Buy) (Disposition to Issuer)
04 Apr 2019	Form 4: Yurasov Sergey, Sr. VP, Clinic. Devel. & CMO Returned 6,136 shares to the issuer ($35.9K) · Disposed of 72,620 Restricted Stock Units (Disposition to Issuer) · Disposed of 333,335 Stock Option (Rt to Buy) (Disposition to Issuer)
04 Apr 2019	Form 4: Brady Stephen R, EVP, Strategy & Finance Returned 17,063 shares to the issuer ($99.8K) · Disposed of 79,536 Restricted Stock Units (Disposition to Issuer) · Disposed of 521,183 Stock Option (Rt to Buy) (Disposition to Issuer)
04 Apr 2019	Form 4: Gombotz Wayne, Chief Development Officer Returned 37,068 shares to the issuer · Disposed of 129,018 Stock Option (Rt to Buy) (Disposition to Issuer)
04 Apr 2019	Form 4: Paya Carlos V, Director Returned 35,576 shares to the issuer ($208K) · Disposed of 121,000 Restricted Stock Units (Disposition to Issuer) · Disposed of 1,515,884 Stock Option (Rt to Buy) (Disposition to Issuer)
04 Apr 2019	Form 4: ter Meulen Jan Henrik, Chief Scientific Officer Returned 14,620 shares to the issuer ($85.5K) · Disposed of 69,362 Restricted Stock Units (Disposition to Issuer) · Disposed of 425,625 Stock Option (Rt to Buy) (Disposition to Issuer)
04 Apr 2019	Form 4: Kelley Susan L., Director Disposed of 35,000 Stock Option (Rt to Buy) (Disposition to Issuer)
04 Apr 2019	Form 4: Penhoet Edward, Director Disposed of 42,339 Stock Option (Rt to Buy) (Disposition to Issuer)
04 Apr 2019	Form 4: Ringo William R, Director Disposed of 35,000 Stock Option (Rt to Buy) (Disposition to Issuer)
04 Apr 2019	Form 4: Coleman Lewis W, Director Returned 175,000 shares to the issuer ($1.02M) · Returned 3,000 shares to the issuer ($17.6K) · Disposed of 35,000 Stock Option (Rt to Buy) (Disposition to Issuer)
02 Apr 2019	Form 4: Column Group L P, 10% owner and 8 others Disposed of 6,642,942 shares (Tender Offer) ($38.9M)
07 Jan 2019	Form 4: Paya Carlos V, Director Received 63,000 shares as a grant or award · Granted 293,000 Stock Option (right to buy) · Sold 13,014 shares ($20.6K)
07 Jan 2019	Form 4: ter Meulen Jan Henrik, Chief Scientific Officer Received 25,000 shares as a grant or award · Granted 120,000 Stock Option (right to buy) · Sold 3,414 shares ($5.41K)
07 Jan 2019	Form 4: Yurasov Sergey, Sr. VP, Clinic. Devel. & CMO Received 25,000 shares as a grant or award · Granted 110,000 Stock Option (right to buy) · Sold 3,522 shares ($5.54K)
07 Jan 2019	Form 4: Brady Stephen R, EVP, Strategy & Finance Received 25,000 shares as a grant or award · Granted 120,000 Stock Option (right to buy) · Sold 5,516 shares ($8.72K)
07 Jan 2019	Form 4: Coleman Lewis W, Director Granted 12,500 Stock Option (right to buy)
07 Jan 2019	Form 4: Ringo William R, Director Granted 12,500 Stock Option (right to buy)
07 Jan 2019	Form 4: Berger Franklin M, Director Granted 12,500 Stock Option (right to buy)
07 Jan 2019	Form 4: Baltimore David, Director Granted 12,500 Stock Option (right to buy)

Comments